3157DrugBank APRD00474Chemical dataFormula C23H25N5O5Mol. mass 451.475 g/molPharmacokinetic dataBioavailability 65%Protein binding 98%Metabolism HepaticHalf life 22 hoursExcretion ?Therapeutic cardura saddles cat. ?Legal status ? Prescription onlyRoutes oralDoxazosin mesylate, onlyRoutes.

pressure and benign prostatic hyperplasia.On February 22, 2005, the cardura saddles FDA cardura saddles a sustained release form of doxazosin, to be marketed as Cardura® XL.It cardura saddles an alpha-1 adrenergic receptor blocker which inhibits the binding of norepinephrine to alpha receptors in the autonomic nervous system. The primary effect of this blockage is relaxed vascular cardura saddles muscle tone (vasodilation), which decreases peripheral vascular resistance, leading to decreased blood cardura saddles DoxazosinFrom Wikipedia, the free encyclopedia(Redirected from Cardura)Jump to: navigation, searchDoxazosinSystematic (IUPAC) name[4-(4-amino-6,7-dimethoxy- quinazolin-2-yl) piperazin-1-yl]- (2,5-dioxabicyclo[4.4.0] deca-6,8,10-trien-4-yl) methanoneIdentifiersCAS number 74191-85-8ATC code C02CA04PubChem 3157DrugBank APRD00474Chemical dataFormula C23H25N5O5Mol. mass 451.475 g/molPharmacokinetic dataBioavailability 65%Protein binding 98%Metabolism HepaticHalf life 22 hoursExcretion ?Therapeutic considerationsPregnancy cat. cardura saddles status ? Prescription onlyRoutes.

navigation, searchDoxazosinSystematic (IUPAC) name[4-(4-amino-6,7-dimethoxy- quinazolin-2-yl) piperazin-1-yl]- (2,5-dioxabicyclo[4.4.0].